Transforming fusions of FGFR and TACC genes in human glioblastoma

Devendra Singh, Joseph Minhow Chan, Pietro Zoppoli, Francesco Niola, Ryan Sullivan, Angelica Castano, Eric Minwei Liu, Jonathan Reichel, Paola Porrati, Serena Pellegatta, Kunlong Qiu, Zhibo Gao, Michele Ceccarelli, Riccardo Riccardi, Daniel J. Brat, Abhijit Guha, Ken Aldape, John G. Golfinos, David Zagzag, Tom Mikkelsen & 4 others Gaetano Finocchiaro, Anna Lasorella, Raul Rabadan, Antonio Iavarone

Research output: Contribution to journalArticle

367 Citations (Scopus)

Abstract

The brain tumor glioblastoma multiforme (GBM) is among the most lethal forms of human cancer. Here, we report that a small subset of GBMs (3.1%; 3 of 97 tumors examined) harbors oncogenic chromosomal translocations that fuse in-frame the tyrosine kinase coding domains of fibroblast growth factor receptor (FGFR) genes (FGFR1 or FGFR3) to the transforming acidic coiled-coil (TACC) coding domains of TACC1 or TACC3, respectively. The FGFR-TACC fusion protein displays oncogenic activity when introduced into astrocytes or stereotactically transduced in the mouse brain. The fusion protein, which localizes to mitotic spindle poles, has constitutive kinase activity and induces mitotic and chromosomal segregation defects and triggers aneuploidy. Inhibition of FGFR kinase corrects the aneuploidy, and oral administration of an FGFR inhibitor prolongs survival of mice harboring intracranial FGFR3-TACC3-initiated glioma. FGFR-TACC fusions could potentially identify a subset of GBM patients who would benefit from targeted FGFR kinase inhibition.

Original languageEnglish
Pages (from-to)1231-1235
Number of pages5
JournalScience
Volume337
Issue number6099
DOIs
Publication statusPublished - 7 Sep 2012
Externally publishedYes

Fingerprint

Fibroblast Growth Factor Receptors
Glioblastoma
Genes
Phosphotransferases
Aneuploidy
Spindle Poles
Genetic Translocation
Spindle Apparatus
Brain Neoplasms
Glioma
Astrocytes
Protein-Tyrosine Kinases
Oral Administration
Gene
Fusion
Neoplasms
Proteins
Brain

ASJC Scopus subject areas

  • General
  • History and Philosophy of Science

Cite this

Singh, D., Chan, J. M., Zoppoli, P., Niola, F., Sullivan, R., Castano, A., ... Iavarone, A. (2012). Transforming fusions of FGFR and TACC genes in human glioblastoma. Science, 337(6099), 1231-1235. https://doi.org/10.1126/science.1220834

Transforming fusions of FGFR and TACC genes in human glioblastoma. / Singh, Devendra; Chan, Joseph Minhow; Zoppoli, Pietro; Niola, Francesco; Sullivan, Ryan; Castano, Angelica; Liu, Eric Minwei; Reichel, Jonathan; Porrati, Paola; Pellegatta, Serena; Qiu, Kunlong; Gao, Zhibo; Ceccarelli, Michele; Riccardi, Riccardo; Brat, Daniel J.; Guha, Abhijit; Aldape, Ken; Golfinos, John G.; Zagzag, David; Mikkelsen, Tom; Finocchiaro, Gaetano; Lasorella, Anna; Rabadan, Raul; Iavarone, Antonio.

In: Science, Vol. 337, No. 6099, 07.09.2012, p. 1231-1235.

Research output: Contribution to journalArticle

Singh, D, Chan, JM, Zoppoli, P, Niola, F, Sullivan, R, Castano, A, Liu, EM, Reichel, J, Porrati, P, Pellegatta, S, Qiu, K, Gao, Z, Ceccarelli, M, Riccardi, R, Brat, DJ, Guha, A, Aldape, K, Golfinos, JG, Zagzag, D, Mikkelsen, T, Finocchiaro, G, Lasorella, A, Rabadan, R & Iavarone, A 2012, 'Transforming fusions of FGFR and TACC genes in human glioblastoma', Science, vol. 337, no. 6099, pp. 1231-1235. https://doi.org/10.1126/science.1220834
Singh D, Chan JM, Zoppoli P, Niola F, Sullivan R, Castano A et al. Transforming fusions of FGFR and TACC genes in human glioblastoma. Science. 2012 Sep 7;337(6099):1231-1235. https://doi.org/10.1126/science.1220834
Singh, Devendra ; Chan, Joseph Minhow ; Zoppoli, Pietro ; Niola, Francesco ; Sullivan, Ryan ; Castano, Angelica ; Liu, Eric Minwei ; Reichel, Jonathan ; Porrati, Paola ; Pellegatta, Serena ; Qiu, Kunlong ; Gao, Zhibo ; Ceccarelli, Michele ; Riccardi, Riccardo ; Brat, Daniel J. ; Guha, Abhijit ; Aldape, Ken ; Golfinos, John G. ; Zagzag, David ; Mikkelsen, Tom ; Finocchiaro, Gaetano ; Lasorella, Anna ; Rabadan, Raul ; Iavarone, Antonio. / Transforming fusions of FGFR and TACC genes in human glioblastoma. In: Science. 2012 ; Vol. 337, No. 6099. pp. 1231-1235.
@article{7867e5f592f44d5fa340ee0e949b824a,
title = "Transforming fusions of FGFR and TACC genes in human glioblastoma",
abstract = "The brain tumor glioblastoma multiforme (GBM) is among the most lethal forms of human cancer. Here, we report that a small subset of GBMs (3.1{\%}; 3 of 97 tumors examined) harbors oncogenic chromosomal translocations that fuse in-frame the tyrosine kinase coding domains of fibroblast growth factor receptor (FGFR) genes (FGFR1 or FGFR3) to the transforming acidic coiled-coil (TACC) coding domains of TACC1 or TACC3, respectively. The FGFR-TACC fusion protein displays oncogenic activity when introduced into astrocytes or stereotactically transduced in the mouse brain. The fusion protein, which localizes to mitotic spindle poles, has constitutive kinase activity and induces mitotic and chromosomal segregation defects and triggers aneuploidy. Inhibition of FGFR kinase corrects the aneuploidy, and oral administration of an FGFR inhibitor prolongs survival of mice harboring intracranial FGFR3-TACC3-initiated glioma. FGFR-TACC fusions could potentially identify a subset of GBM patients who would benefit from targeted FGFR kinase inhibition.",
author = "Devendra Singh and Chan, {Joseph Minhow} and Pietro Zoppoli and Francesco Niola and Ryan Sullivan and Angelica Castano and Liu, {Eric Minwei} and Jonathan Reichel and Paola Porrati and Serena Pellegatta and Kunlong Qiu and Zhibo Gao and Michele Ceccarelli and Riccardo Riccardi and Brat, {Daniel J.} and Abhijit Guha and Ken Aldape and Golfinos, {John G.} and David Zagzag and Tom Mikkelsen and Gaetano Finocchiaro and Anna Lasorella and Raul Rabadan and Antonio Iavarone",
year = "2012",
month = "9",
day = "7",
doi = "10.1126/science.1220834",
language = "English",
volume = "337",
pages = "1231--1235",
journal = "Science",
issn = "0036-8075",
publisher = "American Association for the Advancement of Science",
number = "6099",

}

TY - JOUR

T1 - Transforming fusions of FGFR and TACC genes in human glioblastoma

AU - Singh, Devendra

AU - Chan, Joseph Minhow

AU - Zoppoli, Pietro

AU - Niola, Francesco

AU - Sullivan, Ryan

AU - Castano, Angelica

AU - Liu, Eric Minwei

AU - Reichel, Jonathan

AU - Porrati, Paola

AU - Pellegatta, Serena

AU - Qiu, Kunlong

AU - Gao, Zhibo

AU - Ceccarelli, Michele

AU - Riccardi, Riccardo

AU - Brat, Daniel J.

AU - Guha, Abhijit

AU - Aldape, Ken

AU - Golfinos, John G.

AU - Zagzag, David

AU - Mikkelsen, Tom

AU - Finocchiaro, Gaetano

AU - Lasorella, Anna

AU - Rabadan, Raul

AU - Iavarone, Antonio

PY - 2012/9/7

Y1 - 2012/9/7

N2 - The brain tumor glioblastoma multiforme (GBM) is among the most lethal forms of human cancer. Here, we report that a small subset of GBMs (3.1%; 3 of 97 tumors examined) harbors oncogenic chromosomal translocations that fuse in-frame the tyrosine kinase coding domains of fibroblast growth factor receptor (FGFR) genes (FGFR1 or FGFR3) to the transforming acidic coiled-coil (TACC) coding domains of TACC1 or TACC3, respectively. The FGFR-TACC fusion protein displays oncogenic activity when introduced into astrocytes or stereotactically transduced in the mouse brain. The fusion protein, which localizes to mitotic spindle poles, has constitutive kinase activity and induces mitotic and chromosomal segregation defects and triggers aneuploidy. Inhibition of FGFR kinase corrects the aneuploidy, and oral administration of an FGFR inhibitor prolongs survival of mice harboring intracranial FGFR3-TACC3-initiated glioma. FGFR-TACC fusions could potentially identify a subset of GBM patients who would benefit from targeted FGFR kinase inhibition.

AB - The brain tumor glioblastoma multiforme (GBM) is among the most lethal forms of human cancer. Here, we report that a small subset of GBMs (3.1%; 3 of 97 tumors examined) harbors oncogenic chromosomal translocations that fuse in-frame the tyrosine kinase coding domains of fibroblast growth factor receptor (FGFR) genes (FGFR1 or FGFR3) to the transforming acidic coiled-coil (TACC) coding domains of TACC1 or TACC3, respectively. The FGFR-TACC fusion protein displays oncogenic activity when introduced into astrocytes or stereotactically transduced in the mouse brain. The fusion protein, which localizes to mitotic spindle poles, has constitutive kinase activity and induces mitotic and chromosomal segregation defects and triggers aneuploidy. Inhibition of FGFR kinase corrects the aneuploidy, and oral administration of an FGFR inhibitor prolongs survival of mice harboring intracranial FGFR3-TACC3-initiated glioma. FGFR-TACC fusions could potentially identify a subset of GBM patients who would benefit from targeted FGFR kinase inhibition.

UR - http://www.scopus.com/inward/record.url?scp=84865805666&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865805666&partnerID=8YFLogxK

U2 - 10.1126/science.1220834

DO - 10.1126/science.1220834

M3 - Article

VL - 337

SP - 1231

EP - 1235

JO - Science

JF - Science

SN - 0036-8075

IS - 6099

ER -